Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-21
DOI
10.1002/1878-0261.12931
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Guidelines Insights: Kidney Cancer, Version 2.2020
- (2019) Robert J. Motzer et al. Journal of the National Comprehensive Cancer Network
- Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma
- (2019) Jeanette E. Eckel‐Passow et al. Cancer Medicine
- Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma
- (2018) José I. López et al. Current Urology Reports
- Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma
- (2018) Melissa Bersanelli et al. Immunotherapy
- Carbonic anhydrase XII functions in health and disease
- (2017) Abdul Waheed et al. GENE
- Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte Isolation
- (2016) Jamie M. Sperger et al. CLINICAL CANCER RESEARCH
- Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
- (2016) Johannes Schödel et al. EUROPEAN UROLOGY
- Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients
- (2016) Shijie Liu et al. Oncotarget
- High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1
- (2016) Jennifer L. Schehr et al. PLoS One
- Carbonic anhydrase IX inhibitors in cancer therapy: an update
- (2015) Claudiu T Supuran et al. Future Medicinal Chemistry
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
- (2015) Roberto Iacovelli et al. Targeted Oncology
- An Introduction to Automated Flow Cytometry Gating Tools and Their Implementation
- (2015) Chris P. Verschoor et al. Frontiers in Immunology
- Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
- (2015) Paul C. McDonald et al. Oncotarget
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- CD147 up-regulates calcium-induced chemotaxis, adhesion ability and invasiveness of human neutrophils via a TRPM-7-mediated mechanism
- (2014) Cong-hua Wang et al. RHEUMATOLOGY
- Weak protein–protein interactions revealed by immiscible filtration assisted by surface tension
- (2013) Scott M. Berry et al. ANALYTICAL BIOCHEMISTRY
- Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays
- (2013) Annette Zimpfer et al. BJU INTERNATIONAL
- Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
- (2013) Amin El-Heliebi et al. Journal of Translational Medicine
- Histologic Variations and Immunohistochemical Features of Metastatic Clear Cell Renal Cell Carcinoma
- (2013) Cheol Lee et al. Korean Journal of Pathology
- Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma
- (2012) Jinyang Yuan et al. ACTA HISTOCHEMICA
- Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma
- (2012) Christian Eichelberg et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib
- (2011) Viktor Gruenwald et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interfering with pH regulation in tumours as a therapeutic strategy
- (2011) Dario Neri et al. NATURE REVIEWS DRUG DISCOVERY
- Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma
- (2010) Benjamin Namdarian et al. BJU INTERNATIONAL
- Improved Estimates of Cancer-Specific Survival Rates From Population-Based Data
- (2010) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib
- (2009) Laura Vroling et al. ANGIOGENESIS
- Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Renal Cell Carcinoma Correlates with Prognosis
- (2009) K. Bluemke et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
- (2008) J. Chiche et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search